INDV CIK: 1625297

Indivior Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
353
FY22:
−4.00
FY23:
−300
FY24:
36.0
FY25:
−27.0
Change from FY21 to FY25
millions USD
FY21:
−14.0
FY22:
−222
FY23:
−95.0
FY24:
69.0
FY25:
−66.0
Change from FY21 to FY25
millions USD
FY21:
−94.0
FY22:
−101
FY23:
−64.0
FY24:
−102
FY25:
−30.0
millions USD
FY21:
244
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
349
FY22:
−9.00
FY23:
−308
FY24:
7.00
FY25:
−93.0

All amounts in millions USD Data source:SEC EDGAR